(MedPage Today) — Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma (HCC), but real-world outcomes remain heavily constrained by liver function and comorbidity burden…
A story of love: Hawthorne Heights
We promise it won’t take another 20 years before we come back here in Manila!” shouted Hawthorne Heights vocalist JT...






